| Members |
targetComponentId |
| Epinephrine acid tartrate 0.1% preservative-free eye drops |
Adrenaline only product in ocular dose form |
| Epinephrine bitartrate + pilocarpine hydrochloride 1%/1%wv solution |
Product containing only epinephrine and pilocarpine (medicinal product) |
| Epinephrine bitartrate + pilocarpine hydrochloride 1%/2%wv solution |
Product containing only epinephrine and pilocarpine (medicinal product) |
| Epinephrine bitartrate + pilocarpine hydrochloride 1%/4%wv solution |
Product containing only epinephrine and pilocarpine (medicinal product) |
| Epinephrine bitartrate + pilocarpine hydrochloride 1%/6%wv solution |
Product containing only epinephrine and pilocarpine (medicinal product) |
| Epinephrine bitartrate 5mcg/lidocaine hydrochloride 10mg injection solution vial |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
| Epinephrine hydrochloride 1% solution |
Adrenaline only product |
| Epinephrine hydrochloride 1.9mg dental pellet |
Adrenaline only product in dental dose form |
| Epinephrine hydrochloride 2% solution |
Adrenaline only product |
| Epineural neurolysis |
Destruction - action |
| Epiphyseal cartilage |
Structure of epiphyseal plate (body structure) |
| Epiphysiolysis |
Epiphysiodesis |
| Epirubicin hydrochloride 200mg/100mL solution |
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Epirubicin hydrochloride 2mg/mL infusion solution 100mL vial |
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Epirubicin hydrochloride 2mg/mL injection solution 100mL vial |
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Episcleritis periodica fugax |
Episcleritis |
| Episcleritis periodica fugax |
Episcleritis |
| Episiotomy wound |
Episiotomy wound |
| Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage I |
I |
| Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IA |
IA |
| Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IB |
IB |
| Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IC |
IC |
| Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IIA |
American Joint Committee on Cancer stage IIA (qualifier value) |
| Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IIB |
American Joint Committee on Cancer stage IIB (qualifier value) |
| Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage III |
American Joint Committee on Cancer stage III (qualifier value) |
| Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IIIA |
American Joint Committee on Cancer stage IIIA (qualifier value) |
| Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IIIB |
American Joint Committee on Cancer stage IIIB (qualifier value) |
| Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IIIC |
American Joint Committee on Cancer stage IIIC (qualifier value) |
| Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IV |
IV |
| Epithelial ovarian tumour, FIGO stage IVA |
American Joint Committee on Cancer stage IVA (qualifier value) |
| Epithelial ovarian tumour, FIGO stage IVB |
IVB |
| Epithelial stromal corneal dystrophy |
Epithelial basement membrane dystrophy (disorder) |
| Epithelial tumor, benign, no International Classification of Diseases for Oncology subtype |
Benign epithelial neoplasm |
| Epithelioid hemangioendothelioma |
Epithelioid hemangioendothelioma, malignant (morphologic abnormality) |
| Epoetin alfa 10000unt/mL injection |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Epoetin alfa 10000unt/mL injection solution 1mL vial |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Epoetin alfa 10000unt/mL solution |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Epoetin alfa 20000unt/mL injection solution 1mL vial |
Epoetin alfa 20000 unit/mL solution for injection |
| Epoetin alfa 2000unt/mL injection |
Epoetin alfa 2000 unit/mL solution for injection |
| Epoetin alfa 2000unt/mL injection solution 1mL vial |
Epoetin alfa 2000 unit/mL solution for injection |
| Epoetin alfa 2000unt/mL solution |
Epoetin alfa 2000 unit/mL solution for injection |
| Epoetin alfa 3000unt/mL injection solution 1mL vial |
Product containing precisely epoetin alfa 3000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Epoetin alfa 4000unt/mL injection solution 1mL vial |
Epoetin alfa 4000 unit/mL solution for injection |
| Epoetin alfa 4000unt/mL solution |
Epoetin alfa 4000 unit/mL solution for injection |
| Epoetin beta 10,000iu powder and solvent for injection solution cartridge |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 10,000iu powder for conventional release solution for injection cartridge |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 100,000iu powder and solvent for injection solution vial |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 100,000iu powder for conventional release solution for injection vial |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 20,000iu powder and solvent for injection solution cartridge |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 20,000iu powder for conventional release solution for injection cartridge |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 50,000iu powder and solvent for injection solution vial |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 50,000iu powder for conventional release solution for injection vial |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 500iu powder and solvent for injection solution vial |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 60,000iu powder and solvent for injection solution cartridge |
Epoetin beta only product in parenteral dose form |
| Epoetin beta 60,000iu powder for conventional release solution for injection cartridge |
Epoetin beta only product in parenteral dose form |
| Epoophoron |
Wolffian body rest |
| Epstein syndrome |
MYH9 related disease |
| Eptifibatide 0.75mg injection |
Product containing precisely eptifibatide 750 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Eptifibatide 0.75mg/mL injection |
Product containing precisely eptifibatide 750 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Eptifibatide 0.75mg/mL injection solution 100mL bag |
Product containing precisely eptifibatide 750 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Eptifibatide 750micrograms/mL infusion solution 100mL vial |
Product containing precisely eptifibatide 750 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Equine anti-human thymocyte immunoglobulin 20mg/mL injection solution 5mL vial |
Product containing precisely equine antithymocyte immunoglobulin 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Equine arteritis virus antibody |
Viral antibody |
| Equine infectious anemia virus antibody |
Viral antibody |
| Equus asinus asinus |
Equus asinus |
| Ergonovine maleate 200mcg/mL injection solution ampule |
Ergometrine 200 microgram/mL solution for injection |
| Ergot compound allergy |
Allergy to ergot alkaloid (finding) |
| Eribulin mesylate 0.5mg/mL conventional release solution for injection |
Product containing only eribulin in parenteral dose form (medicinal product form) |
| Eribulin mesylate 0.5mg/mL solution for intravenous infusion |
Product containing only eribulin in parenteral dose form (medicinal product form) |
| Erroneous concept |
Erroneous component (foundation metadata concept) |
| Ertapenem 1g powder for infusion solution vial |
Ertapenem (as ertapenem sodium) 1 g powder for solution for injection vial |
| Erwinia ananas |
Pantoea ananatis (organism) |
| Erwinia cacticida |
Pectobacterium cacticida (organism) |
| Erwinia cancerogena |
Enterobacter cancerogenus |
| Erwinia carnegieana |
Genus Dickeya (organism) |
| Erwinia carotovora |
Pectobacterium carotovorum (organism) |
| Erwinia carotovora ss. atroseptica |
Pectobacterium atrosepticum (organism) |
| Erwinia carotovora ss. betavasculorum |
Pectobacterium betavasculorum (organism) |
| Erwinia carotovora ss. carotovora |
Pectobacterium carotovorum subspecies carotovorum (organism) |
| Erwinia carotovora subsp odorifera |
Pectobacterium carotovorum subspecies odoriferum (organism) |
| Erwinia cartovora subsp cartobora |
Pectobacterium carotovorum subspecies carotovorum (organism) |
| Erwinia cartovora subsp wasabiae |
Pectobacterium wasabiae (organism) |
| Erwinia chrysanthemi |
Dickeya chrysanthemi (organism) |
| Erwinia cypripedii |
Pantoea cypripedii (organism) |
| Erwinia herbicola |
Pantoea agglomerans |
| Erwinia nigrifluens |
Brenneria nigrifluens (organism) |
| Erwinia paradisiaca |
Dickeya paradisiaca (organism) |
| Erwinia quercina |
Lonsdalea quercina (organism) |
| Erwinia rhapontici |
Pectobacterium rhapontici (organism) |
| Erwinia rubrifaciens |
Brenneria rubrifaciens (organism) |
| Erwinia salicis |
Brenneria salicis (organism) |
| Erwinia stewartii |
Pantoea stewartii subsp stewartii |
| Erwinia uredovora |
Pantoea ananatis (organism) |
| Erythema infectiosum virus |
Primate erythroparvovirus 1 (organism) |
| Erythromycin 250mg e/c granules in capsule |
Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug) |
| Erythromycin 250mg gastro-resistant oral capsule |
Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug) |
| Erythromycin 250mg m/r capsule |
Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug) |
| Erythromycin ethylsuccinate 100 mg/2.5mL |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 100mg/2.5mL oral suspension |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 100mg/2.5mL suspension |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 200mg/5mL |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
FHIR